Cargando…
Considerations and guidance in designing equity-relevant clinical trials
Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about h...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460332/ https://www.ncbi.nlm.nih.gov/pubmed/28583125 http://dx.doi.org/10.1186/s12939-017-0591-1 |
_version_ | 1783242149093965824 |
---|---|
author | Mbuagbaw, Lawrence Aves, Theresa Shea, Beverley Jull, Janet Welch, Vivian Taljaard, Monica Yoganathan, Manosila Greer-Smith, Regina Wells, George Tugwell, Peter |
author_facet | Mbuagbaw, Lawrence Aves, Theresa Shea, Beverley Jull, Janet Welch, Vivian Taljaard, Monica Yoganathan, Manosila Greer-Smith, Regina Wells, George Tugwell, Peter |
author_sort | Mbuagbaw, Lawrence |
collection | PubMed |
description | Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about how to build consideration of health inequities into trials. Due consideration of health inequities is important to inform the design, conduct and reporting of trials so that research can build evidence to more effectively address health inequities and importantly, ensure that inequities are not aggravated. In this paper, we discuss approaches to integrating health equity-considerations in randomized trials by using the PROGRESS Plus framework (Place of residence, Race/ethnicity/culture/language, Occupation, Gender, Religion, Education, Socio-economic status, Social capital and “Plus” that includes other context specific factors) and cover: (i) formulation of research questions, (ii) two specific scenarios relevant to trials about health equity and (iii) describe how the PROGRESS Plus characteristics may influence trial design, conduct and analyses. This guidance is intended to support trialists designing equity-relevant trials and lead to better design, conduct, analyses and reporting, by addressing two main issues: how to avoid aggravating inequity among research participants and how to produce information that is useful to decision-makers who are concerned with health inequities. |
format | Online Article Text |
id | pubmed-5460332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54603322017-06-07 Considerations and guidance in designing equity-relevant clinical trials Mbuagbaw, Lawrence Aves, Theresa Shea, Beverley Jull, Janet Welch, Vivian Taljaard, Monica Yoganathan, Manosila Greer-Smith, Regina Wells, George Tugwell, Peter Int J Equity Health Commentary Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about how to build consideration of health inequities into trials. Due consideration of health inequities is important to inform the design, conduct and reporting of trials so that research can build evidence to more effectively address health inequities and importantly, ensure that inequities are not aggravated. In this paper, we discuss approaches to integrating health equity-considerations in randomized trials by using the PROGRESS Plus framework (Place of residence, Race/ethnicity/culture/language, Occupation, Gender, Religion, Education, Socio-economic status, Social capital and “Plus” that includes other context specific factors) and cover: (i) formulation of research questions, (ii) two specific scenarios relevant to trials about health equity and (iii) describe how the PROGRESS Plus characteristics may influence trial design, conduct and analyses. This guidance is intended to support trialists designing equity-relevant trials and lead to better design, conduct, analyses and reporting, by addressing two main issues: how to avoid aggravating inequity among research participants and how to produce information that is useful to decision-makers who are concerned with health inequities. BioMed Central 2017-06-05 /pmc/articles/PMC5460332/ /pubmed/28583125 http://dx.doi.org/10.1186/s12939-017-0591-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Mbuagbaw, Lawrence Aves, Theresa Shea, Beverley Jull, Janet Welch, Vivian Taljaard, Monica Yoganathan, Manosila Greer-Smith, Regina Wells, George Tugwell, Peter Considerations and guidance in designing equity-relevant clinical trials |
title | Considerations and guidance in designing equity-relevant clinical trials |
title_full | Considerations and guidance in designing equity-relevant clinical trials |
title_fullStr | Considerations and guidance in designing equity-relevant clinical trials |
title_full_unstemmed | Considerations and guidance in designing equity-relevant clinical trials |
title_short | Considerations and guidance in designing equity-relevant clinical trials |
title_sort | considerations and guidance in designing equity-relevant clinical trials |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460332/ https://www.ncbi.nlm.nih.gov/pubmed/28583125 http://dx.doi.org/10.1186/s12939-017-0591-1 |
work_keys_str_mv | AT mbuagbawlawrence considerationsandguidanceindesigningequityrelevantclinicaltrials AT avestheresa considerationsandguidanceindesigningequityrelevantclinicaltrials AT sheabeverley considerationsandguidanceindesigningequityrelevantclinicaltrials AT julljanet considerationsandguidanceindesigningequityrelevantclinicaltrials AT welchvivian considerationsandguidanceindesigningequityrelevantclinicaltrials AT taljaardmonica considerationsandguidanceindesigningequityrelevantclinicaltrials AT yoganathanmanosila considerationsandguidanceindesigningequityrelevantclinicaltrials AT greersmithregina considerationsandguidanceindesigningequityrelevantclinicaltrials AT wellsgeorge considerationsandguidanceindesigningequityrelevantclinicaltrials AT tugwellpeter considerationsandguidanceindesigningequityrelevantclinicaltrials |